Skip to main content
Top
Published in: Endocrine 3/2017

01-03-2017 | Original Article

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome

Authors: Alessandro Prete, Rosa Maria Paragliola, Filomena Bottiglieri, Carlo Antonio Rota, Alfredo Pontecorvi, Roberto Salvatori, Salvatore Maria Corsello

Published in: Endocrine | Issue 3/2017

Login to get access

Abstract

Successful treatment of Cushing syndrome causes transient or permanent adrenal insufficiency deriving from endogenous hypercortisolism-induced hypothalamus–pituitary–adrenal–axis suppression. We analyzed pre-treatment factors potentially affecting the duration of adrenal insufficiency. We conducted a retrospective analysis on patients successfully treated for Cushing disease (15 patients) who underwent transsphenoidal surgery, and nonmalignant primary adrenal Cushing syndrome (31 patients) who underwent unilateral adrenalectomy, divided into patients with overt primary adrenal Cushing syndrome (14 patients) and subclinical primary adrenal Cushing syndrome (17 patients). Epidemiological data, medical history, and hormonal parameters depending on the etiology of hypercortisolism were collected and compared to the duration of adrenal insufficiency. The median duration of follow-up after surgery for Cushing disease and primary adrenal Cushing syndrome was 70 and 48 months, respectively. In the Cushing disease group, the median duration of adrenal insufficiency after transsphenoidal surgery was 15 months: younger age at diagnosis and longer duration of signs and symptoms of hypercortisolism before diagnosis and surgery were associated with longer duration of adrenal insufficiency. The median duration of adrenal insufficiency was 6 months for subclinical primary adrenal Cushing syndrome and 18.5 months for overt primary adrenal Cushing syndrome. The biochemical severity of hypercortisolism, the grade of hypothalamus–pituitary–adrenal–axis suppression, and treatment with ketoconazole before surgery accounted for longer duration of adrenal insufficiency. In patients with Cushing disease, younger age and delayed diagnosis and treatment predict longer need for glucocorticoid replacement therapy after successful transsphenoidal surgery. In patients with primary adrenal Cushing syndrome, the severity of hypercortisolism plays a primary role in influencing the duration of adrenal insufficiency after unilateral adrenalectomy.
Literature
2.
3.
go back to reference C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015). doi:10.1210/jc.2014-3632 CrossRefPubMed C.M. Berr, G. Di Dalmazi, A. Osswald, K. Ritzel, M. Bidlingmaier, L.L. Geyer, M. Treitl, K. Hallfeldt, W. Rachinger, N. Reisch, R. Blaser, J. Schopohl, F. Beuschlein, M. Reincke, Time to recovery of adrenal function after curative surgery for Cushing’s syndrome depends on etiology. J. Clin. Endocrinol. Metab. 100(4), 1300–1308 (2015). doi:10.​1210/​jc.​2014-3632 CrossRefPubMed
4.
go back to reference T. Deutschbein, M. Broecker-Preuss, M.F. Hartmann, R. Althoff, S.A. Wudy, K. Mann, S. Petersenn, Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm. Metab. Res. 43(10), 714–719 (2011). doi:10.1055/s-0031-1286297 CrossRefPubMed T. Deutschbein, M. Broecker-Preuss, M.F. Hartmann, R. Althoff, S.A. Wudy, K. Mann, S. Petersenn, Measurement of urinary free cortisol by current immunoassays: need for sex-dependent reference ranges to define hypercortisolism. Horm. Metab. Res. 43(10), 714–719 (2011). doi:10.​1055/​s-0031-1286297 CrossRefPubMed
5.
go back to reference S. Persichilli, J. Gervasoni, F. Iavarone, C. Zuppi, A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin. Chem. Lab. Med. 48(10), 1433–1437 (2010). doi:10.1515/CCLM.2010.282 CrossRefPubMed S. Persichilli, J. Gervasoni, F. Iavarone, C. Zuppi, A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose. Clin. Chem. Lab. Med. 48(10), 1433–1437 (2010). doi:10.​1515/​CCLM.​2010.​282 CrossRefPubMed
6.
go back to reference M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, M. Toth, Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur. J. Endocrinol. 160(4), 647–655 (2009). doi:10.1530/EJE-08-0707 CrossRefPubMed M. Sereg, A. Szappanos, J. Toke, K. Karlinger, K. Feldman, E. Kaszper, I. Varga, E. Glaz, K. Racz, M. Toth, Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur. J. Endocrinol. 160(4), 647–655 (2009). doi:10.​1530/​EJE-08-0707 CrossRefPubMed
7.
go back to reference M. Terzolo, S. Bovio, A. Pia, P.A. Conton, G. Reimondo, C. Dall’Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, B. Ambrosi, F. Mantero, Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153(2), 307–315 (2005). doi:10.1530/eje.1.01959 CrossRefPubMed M. Terzolo, S. Bovio, A. Pia, P.A. Conton, G. Reimondo, C. Dall’Asta, D. Bemporad, A. Angeli, G. Opocher, M. Mannelli, B. Ambrosi, F. Mantero, Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur. J. Endocrinol. 153(2), 307–315 (2005). doi:10.​1530/​eje.​1.​01959 CrossRefPubMed
9.
go back to reference F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 91(1), 7–13 (2006). doi:10.1210/jc.2005-1204 CrossRefPubMed F. Esposito, J.R. Dusick, P. Cohan, P. Moftakhar, D. McArthur, C. Wang, R.S. Swerdloff, D.F. Kelly, Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J. Clin. Endocrinol. Metab. 91(1), 7–13 (2006). doi:10.​1210/​jc.​2005-1204 CrossRefPubMed
10.
go back to reference G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J. Clin. Endocrinol. Metab. 99(8), 2637–2645 (2014). doi:10.1210/jc.2014-1401 CrossRefPubMed G. Di Dalmazi, C.M. Berr, M. Fassnacht, F. Beuschlein, M. Reincke, Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing’s syndrome: a systematic review of the literature. J. Clin. Endocrinol. Metab. 99(8), 2637–2645 (2014). doi:10.​1210/​jc.​2014-1401 CrossRefPubMed
11.
go back to reference P.A. Fitzgerald, D.C. Aron, J.W. Findling, R.M. Brooks, C.B. Wilson, P.H. Forsham, J.B. Tyrrell, Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54(2), 413–422 (1982). doi:10.1210/jcem-54-2-413 CrossRefPubMed P.A. Fitzgerald, D.C. Aron, J.W. Findling, R.M. Brooks, C.B. Wilson, P.H. Forsham, J.B. Tyrrell, Cushing’s disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54(2), 413–422 (1982). doi:10.​1210/​jcem-54-2-413 CrossRefPubMed
12.
go back to reference A.R. Hermus, G.F. Pieters, G.J. Pesman, E. Meijer, A.G. Smals, T.J. Benraad, P.W. Kloppenborg, Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing’s disease?. J. Endocrinol. Invest. 10(4), 365–369 (1987). doi:10.1007/BF03348149 CrossRefPubMed A.R. Hermus, G.F. Pieters, G.J. Pesman, E. Meijer, A.G. Smals, T.J. Benraad, P.W. Kloppenborg, Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing’s disease?. J. Endocrinol. Invest. 10(4), 365–369 (1987). doi:10.​1007/​BF03348149 CrossRefPubMed
13.
go back to reference J. Flitsch, D.K. Ludecke, U.J. Knappe, W. Saeger, Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp. Clin. Endocrinol. Diabetes 107(3), 183–189 (1999). doi:10.1055/s-0029-1212095 CrossRefPubMed J. Flitsch, D.K. Ludecke, U.J. Knappe, W. Saeger, Correlates of long-term hypocortisolism after transsphenoidal microsurgery for Cushing’s disease. Exp. Clin. Endocrinol. Diabetes 107(3), 183–189 (1999). doi:10.​1055/​s-0029-1212095 CrossRefPubMed
14.
15.
go back to reference D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.1210/jcem.80.11.7593411 PubMed D. Bochicchio, M. Losa, M. Buchfelder, Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s disease survey group. J. Clin. Endocrinol. Metab. 80(11), 3114–3120 (1995). doi:10.​1210/​jcem.​80.​11.​7593411 PubMed
16.
17.
go back to reference S.H. Roerink, M.A. Wagenmakers, J.W. Smit, E.F. van Rossum, R.T. Netea-Maier, T.S. Plantinga, A.R. Hermus, Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome. Endocrine (2016). doi:10.1007/s12020-016-0883-z S.H. Roerink, M.A. Wagenmakers, J.W. Smit, E.F. van Rossum, R.T. Netea-Maier, T.S. Plantinga, A.R. Hermus, Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing’s syndrome. Endocrine (2016). doi:10.​1007/​s12020-016-0883-z
18.
go back to reference O. Ragnarsson, C.A. Glad, P. Berglund, R. Bergthorsdottir, D.N. Eder, G. Johannsson, Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. J. Clin. Endocrinol. Metab. 99(9), E1803–1807 (2014). doi:10.1210/jc.2014-1906 CrossRefPubMed O. Ragnarsson, C.A. Glad, P. Berglund, R. Bergthorsdottir, D.N. Eder, G. Johannsson, Common genetic variants in the glucocorticoid receptor and the 11beta-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing’s syndrome in remission. J. Clin. Endocrinol. Metab. 99(9), E1803–1807 (2014). doi:10.​1210/​jc.​2014-1906 CrossRefPubMed
19.
go back to reference L. Trementino, G. Appolloni, C. Concettoni, M. Cardinaletti, M. Boscaro, G. Arnaldi, Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. Eur. J. Endocrinol. 166(1), 35–42 (2012). doi:10.1530/EJE-11-0722 CrossRefPubMed L. Trementino, G. Appolloni, C. Concettoni, M. Cardinaletti, M. Boscaro, G. Arnaldi, Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing’s syndrome. Eur. J. Endocrinol. 166(1), 35–42 (2012). doi:10.​1530/​EJE-11-0722 CrossRefPubMed
20.
go back to reference M.P. Ricciato, V. Di Donna, G. Perotti, A. Pontecorvi, R. Bellantone, S.M. Corsello, The role of adrenal scintigraphy in the diagnosis of subclinical Cushing’s syndrome and the prediction of post-surgical hypoadrenalism. World J. Surg. 38(6), 1328–1335 (2014). doi:10.1007/s00268-014-2482-6 PubMed M.P. Ricciato, V. Di Donna, G. Perotti, A. Pontecorvi, R. Bellantone, S.M. Corsello, The role of adrenal scintigraphy in the diagnosis of subclinical Cushing’s syndrome and the prediction of post-surgical hypoadrenalism. World J. Surg. 38(6), 1328–1335 (2014). doi:10.​1007/​s00268-014-2482-6 PubMed
21.
go back to reference L.M. Fig, M.D. Gross, B. Shapiro, D.A. Ehrmann, J.E. Freitas, D.E. Schteingart, G.M. Glazer, I.R. Francis, Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann. Intern. Med. 109(7), 547–553 (1988)CrossRefPubMed L.M. Fig, M.D. Gross, B. Shapiro, D.A. Ehrmann, J.E. Freitas, D.E. Schteingart, G.M. Glazer, I.R. Francis, Adrenal localization in the adrenocorticotropic hormone-independent Cushing syndrome. Ann. Intern. Med. 109(7), 547–553 (1988)CrossRefPubMed
22.
go back to reference D. Rubello, C. Bui, D. Casara, M.D. Gross, L.M. Fig, B. Shapiro, Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol. 147(1), 13–28 (2002)CrossRefPubMed D. Rubello, C. Bui, D. Casara, M.D. Gross, L.M. Fig, B. Shapiro, Functional scintigraphy of the adrenal gland. Eur. J. Endocrinol. 147(1), 13–28 (2002)CrossRefPubMed
24.
go back to reference F. Donadio, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Carletto, M. Castellani, L. Dellavedova, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J. Endocrinol. Invest. 32(7), 576–580 (2009). doi:10.3275/6360 CrossRefPubMed F. Donadio, V. Morelli, A.S. Salcuni, C. Eller-Vainicher, M. Carletto, M. Castellani, L. Dellavedova, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass. J. Endocrinol. Invest. 32(7), 576–580 (2009). doi:10.​3275/​6360 CrossRefPubMed
26.
go back to reference J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. 43(5), 545–550 (1995)CrossRef J. Newell-Price, P. Trainer, L. Perry, J. Wass, A. Grossman, M. Besser, A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing’s syndrome. Clin. Endocrinol. 43(5), 545–550 (1995)CrossRef
27.
go back to reference F. Pecori Giraldi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92(11), 4123–4129 (2007). doi:10.1210/jc.2007-0596 CrossRefPubMed F. Pecori Giraldi, A.G. Ambrogio, M. De Martin, L.M. Fatti, M. Scacchi, F. Cavagnini, Specificity of first-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J. Clin. Endocrinol. Metab. 92(11), 4123–4129 (2007). doi:10.​1210/​jc.​2007-0596 CrossRefPubMed
28.
go back to reference J. Shen, M. Sun, B. Zhou, J. Yan, Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy?. Eur. J. Endocrinol. 171(4), 421–431 (2014). doi:10.1530/EJE-14-0345 CrossRefPubMed J. Shen, M. Sun, B. Zhou, J. Yan, Nonconformity in the clinical practice guidelines for subclinical Cushing’s syndrome: which guidelines are trustworthy?. Eur. J. Endocrinol. 171(4), 421–431 (2014). doi:10.​1530/​EJE-14-0345 CrossRefPubMed
29.
go back to reference M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, Italian Association of Clinical, E.: AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851–870 (2011). doi:10.1530/EJE-10-1147 CrossRefPubMed M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi, G. Reimondo, A. Pia, V. Toscano, M. Zini, G. Borretta, E. Papini, P. Garofalo, B. Allolio, B. Dupas, F. Mantero, A. Tabarin, Italian Association of Clinical, E.: AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164(6), 851–870 (2011). doi:10.​1530/​EJE-10-1147 CrossRefPubMed
30.
go back to reference C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur. J. Endocrinol. 162(1), 91–99 (2010). doi:10.1530/EJE-09-0775 CrossRefPubMed C. Eller-Vainicher, V. Morelli, A.S. Salcuni, M. Torlontano, F. Coletti, L. Iorio, A. Cuttitta, A. Ambrosio, L. Vicentini, V. Carnevale, P. Beck-Peccoz, M. Arosio, B. Ambrosi, A. Scillitani, I. Chiodini, Post-surgical hypocortisolism after removal of an adrenal incidentaloma: is it predictable by an accurate endocrinological work-up before surgery?. Eur. J. Endocrinol. 162(1), 91–99 (2010). doi:10.​1530/​EJE-09-0775 CrossRefPubMed
31.
go back to reference S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157(6), 725–731 (2007). doi:10.1530/EJE-07-0424 CrossRefPubMed S. Kidambi, H. Raff, J.W. Findling, Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing’s syndrome. Eur. J. Endocrinol. 157(6), 725–731 (2007). doi:10.​1530/​EJE-07-0424 CrossRefPubMed
33.
go back to reference N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H. Shackleton, Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3-5), 496–504 (2010). doi:10.1016/j.jsbmb.2010.04.010 CrossRefPubMedPubMedCentral N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, C.H. Shackleton, Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol. 121(3-5), 496–504 (2010). doi:10.​1016/​j.​jsbmb.​2010.​04.​010 CrossRefPubMedPubMedCentral
Metadata
Title
Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome
Authors
Alessandro Prete
Rosa Maria Paragliola
Filomena Bottiglieri
Carlo Antonio Rota
Alfredo Pontecorvi
Roberto Salvatori
Salvatore Maria Corsello
Publication date
01-03-2017
Publisher
Springer US
Published in
Endocrine / Issue 3/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1007-5

Other articles of this Issue 3/2017

Endocrine 3/2017 Go to the issue